Find your next paid study

RIVER FoundationNCT06038409

Actual pay is set by the research site.

Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder

This study aims to examine the effects of Low-Intensity Focused Ultrasound (LIFU) on brain activity in patients with alcohol use disorder.

Alcohol Use Disorder

University of California, San FranciscoNCT06518785

~$10 – $675

Actual pay is set by the research site.

Transformative Research In DiabEtic NephropaThy

This is a prospective, observational, cohort study of patients with a clinical diagnosis of diabetes who are undergoing clinically indicated kidney biopsy. The…

Diabetic NephropathiesDiabetic Glomerulosclerosis

University of PennsylvaniaNCT02986984

Actual pay is set by the research site.

Freezing of Gait Symptoms in Parkinson Disease

A Novel Instrument to Address Freezing of Gait in Parkinson's Patients

The goal of this clinical trial is to learn if the ParkinSense system, a customizable, multimodal, and adaptable cueing system, can assist with freezing of gai…

Barron Associates, Inc.NCT07542743

~$10 – $1,050

Actual pay is set by the research site.

Proton Therapy Patient Registry

The purpose of this study is to establish a database (or "registry") of patients treated with proton beam therapy at the University Hospitals (UH) Proton Thera…

Treatment With Proton Beam Radiation Therapy

Case Comprehensive Cancer CenterNCT02986048

Actual pay is set by the research site.

Phase 2

A Phase II Neoadjuvant Clinical Trial of the Androgen Receptor Inhibitor Darolutamide in Early-Stage Androgen Receptor Positive (AR+) Triple-Negative Breast Cancer

This phase II trial compares the effect of adding darolutamide to standard therapy versus standard therapy alone before surgery for the treatment of patients w…

Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Triple-Negative Breast Carcinoma

Vandana AbramsonNCT07016399

~$75 – $3,000

Actual pay is set by the research site.

Phase 3

Phase 3b, Open-label, Multicenter, Single-dose Study Investigating Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy Administered to Adult Subjects With Severe or Moderately Severe Hemophilia B With Detectable Pretreatment AAV5 Neutralizing Antibodies

The purpose of this study is to assess the risk of bleeding due to failure of expected pharmacological action of CSL222 in adults with severe or moderately sev…

Hemophilia B

~$50 – $2,250

Actual pay is set by the research site.

CSL BehringNCT06003387

Phase 1

Phase 1 Trial of Engineered HSV-1 M032 in Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

The goal of this clinical research study is to learn about the safety and effects of M032 given directly into the tumor in children and adults with DMG and who…

Glioma

M.D. Anderson Cancer CenterNCT07076498

~$150 – $3,000

Actual pay is set by the research site.

Acute Abstinence From Cigarettes vs E-cigarettes (ENDS)

A Laboratory Study of Behavior and Performance Among People Who Vape Nicotine and/or Smoke Cigarettes - Schizophrenia Supplement

The proposed research will characterize withdrawal among people with schizophrenia who vape daily compared to people with schizophrenia who smoke combustible c…

State University of New York at BuffaloNCT06944847

Actual pay is set by the research site.

Natural History, Diagnosis, and Outcomes for Leukodystrophies

The goals of this protocol is to diagnose, care for, and understand the clinical histories and outcomes of people with leukodystrophies.

Leukodystrophy

University of UtahNCT03639285

Actual pay is set by the research site.

Phase 3

A Phase III, Randomised, Open-label, Sponsor-blinded, Multicentre Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

This is a Phase III, randomised, open-label, sponsor-blinded, 3-arm, multicentre, global study assessing the efficacy and safety of rilvegostomig in combinatio…

Hepatocellular Carcinoma

~$50 – $2,250

Actual pay is set by the research site.

AstraZenecaNCT06921785

Ovarian FailureOvarian InsufficiencyMenopause Ovarian Failure+3 more

Ovarian Tissue Allo-Transplantation in the Setting of Primary Ovarian Insufficiency Between Non-Genetically Identical Siblings With Use of Immunosuppression

Premature ovarian failure, also known as primary ovarian insufficiency (POI), or premature menopause, affects 1-2% of women under 40. The diagnosis is typicall…